Page last updated: 2024-10-18

dalteparin and Chlamydia Infections

dalteparin has been researched along with Chlamydia Infections in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Chlamydia Infections: Infections with bacteria of the genus CHLAMYDIA.

Research Excerpts

ExcerptRelevanceReference
"In 256 patients participating in the FRISC trial, evaluating the effects of dalteparin (a low molecular weight heparin) in unstable angina or non-Q wave myocardial infarction, Chlamydia pneumoniae IgA antibody titres and levels of fibrinogen, C-reactive protein and troponin T were determined at inclusion."3.70Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease. ( Gnarpe, H; Gnarpe, J; Lindahl, B; Siegbahn, A; Toss, H; Wallentin, L, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Toss, H1
Gnarpe, J1
Gnarpe, H1
Siegbahn, A1
Lindahl, B1
Wallentin, L1

Other Studies

1 other study available for dalteparin and Chlamydia Infections

ArticleYear
Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease.
    European heart journal, 1998, Volume: 19, Issue:4

    Topics: Angina, Unstable; Antibodies, Anti-Idiotypic; Anticoagulants; Biomarkers; C-Reactive Protein; Chlamy

1998